热门资讯> 正文
BioRobotics在CEO退休后被解雇
2025-07-25 23:23
- Shares of Procept BioRobotics (NASDAQ:PRCT) fell ~9% on Friday after the surgical robotics company announced that its CEO, Reza Zadno, would retire effective Sept. 1, and Larry Wood, a member of the board of directors, would succeed him.
- Concurrently, the San Jose, California-based MedTech also preannounced its Q2 2025 results, indicating $79.2M in revenue, which exceeded $76.1M in FactSet consensus.
- Wood joins Procept (NASDAQ:PRCT) on Sept. 2 from Edwards Lifesciences (EW), where he has functioned as corporate vice president and group president at the heart device maker’s Transcatheter Aortic Valve Replacement and Surgical Structural Heart units since 2023.
- “On behalf of the board of directors, I want to thank Reza for his dedication to the Company and its mission over the past five years,” PRCT’s chair, Thomas Prescott, said.
More on Procept
- PROCEPT BioRobotics: A 'Razor And Razor Blade' Business Model
- Seeking Alpha’s Quant Rating on Procept
- Historical earnings data for Procept
- Financial information for Procept
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
